Our Impact
With the launch of GBM AGILE, a new path has been uncovered—one that accelerates this pace of discovery from bench to bedside, and offers the greatest hope in the fight against cancer. Many important milestones have already been achieved, but there’s so much more on the horizon. Take a look and see how the generous support of our donors is making a difference, one dollar at a time.
“In the era of precision medicine, doctors want to use genetics to select the most effective drugs for each individual patient. It’s time to move beyond individual cancer types – different colored ribbons. By way of precision medicine, we will find cures for all types of cancer. By supporting NFCR’s scientists in their invaluable research endeavors, you are helping pave the way to do exactly that: cure cancer. We have all been affected by cancer in some way or other, or know those who have been. Make a decision to support them. Make a decision to help NFCR pave the way to finding a cure. Together, performing for ALL CANCERS, ALL COLORS, and through ALL ARTS, we will make a difference.” - Robin Xiaoge Wang, Chair, Arts4TheCure
Robin Xiaoge Wang, Chair, Arts4TheCure
Our Progress
Milestones We’ve Achieved Together
38 Trial Sites in the United States
1500 Patients Screened
30+ Global Sites Selected
6 Pharmaceutical Partners
In addition to the progress already achieved, the AGILE trial design will make an even greater impact. The AGILE trial approach will be used to combat other rare and deadly diseases, in the near future.
